GPP
WINT

Great Point Partners’s Windtree Therapeutics Inc WINT Stock Holding History

Great Point Partners’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-180,752
Closed -$759K – 34
2015
Q3 		$759K Buy
+180,752
New +$1.2M 0.3% 34

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Great Point Partners's WINT Position: Q4 2015 in Review

Great Point Partners sold out of Windtree Therapeutics Inc (WINT) in Q4 2015, closing a stake of 180,752 shares — an estimated $759K sold.

Great Point Partners first reported a position in WINT in Q3 2015 and held it in 1 quarter. The position peaked at $759K in Q3 2015. 53 funds tracked by Wall St. Rank hold WINT as of Q4 2015.

  • Great Point Partners reported no remaining Windtree Therapeutics Inc position as of Q4 2015 after selling out during the quarter.
  • Great Point Partners sold 180,752 Windtree Therapeutics Inc shares in Q4 2015, an estimated $759K.
  • Great Point Partners first reported a position in Windtree Therapeutics Inc in Q3 2015 and held it in 1 quarter.
  • Great Point Partners's Windtree Therapeutics Inc position peaked at $759K in Q3 2015.
  • 53 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2015.

Based on Great Point Partners's 13F filing for Q4 2015, filed 16 Feb 2016.